Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Neurotrauma|September 22, 2001
Alterations in immune cell phenotype and function after experimental spinal cord injuryP G Popovich, S Stuckman, I E Gienapp, et al.Immunology and Cell Biology|April 29, 1998
Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: demonstration of T cell anergyS D Jewell, I E Gienapp, K L Cox, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1991
Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergyC C Whitacre, I E Gienapp, C G Orosz, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1995
Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitisN H Javed, I E Gienapp, K L Cox, et al.Clinical Immunology and Immunopathology|September 1, 1996
Treatment of autoimmune disease by oral tolerance to autoantigensC C Whitacre, I E Gienapp, A Meyer, et al.Annals of the New York Academy of Sciences|February 13, 1996
Oral tolerance in experimental autoimmune encephalomyelitisC C Whitacre, I E Gienapp, A Meyer, et al.Journal of Neuroimmunology|March 1, 2000
Neuroendocrine modulation of chronic relapsing experimental autoimmune encephalomyelitis: a critical role for the hypothalamic-pituitary-adrenal axisK C Dowdell, I E Gienapp, S Stuckman, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1996
Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic proteinA L Meyer, J M Benson, I E Gienapp, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
A retro-inverso peptide mimic of CD28 encompassing the MYPPPY motif adopts a polyproline type II helix and inhibits encephalitogenic T cells in vitroM Srinivasan, R M Wardrop, I E Gienapp, et al.Carcinogenesis|April 1, 1991
Facilitation of dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by restraint stress: role of beta-endorphin, prolactin and naltrexoneG A Tejwani, K P Gudehithlu, S H Hanissian, et al.Pageof 2